论文部分内容阅读
目的探讨血小板水平对心内科危重症患者预后影响。方法 93例心内科住院患者,根据血常规血小板数量和急性生理和慢性健康状况评分(APACHEⅡ评分),结合住院是否存在血小板数量减少分为血小板减少组(36例)和正常组(57例)。血小板减少组中取一个亚组(血小板减少>30%组,24例)。分析减少组及其亚组与正常组患者血小板水平及预后。结果血小板减少组及其亚组血小板水平、APACHEⅡ死亡率与正常组患者比较,差异有统计学意义(P<0.05)。结论血小板水平对评估危重病患者的病情和预后具有一定的临床意义。
Objective To investigate the effect of platelet on the prognosis of critically ill patients in cardiology department. Methods A total of 93 inpatients with cardiology department were divided into thrombocytopenia group (36 cases) and normal group (57 cases) according to the number of platelets in blood and acute physiology and chronic health status (APACHEⅡscores). Thrombocytopenia group to take a subgroup (thrombocytopenia> 30% group, 24 cases). Analysis reduce platelet levels and prognosis in patients with subgroups and normal controls. Results Compared with normal group, the difference of thrombocytopenia group and its subgroup platelet count and APACHE Ⅱ mortality was statistically significant (P <0.05). Conclusion The platelet level has some clinical significance for evaluating the condition and prognosis of critically ill patients.